Form 4 for PFE Pfizer
Accepted 2023-03-17 00:00:00 ET · period of report 2023-02-24 · accession 0001225208-23-004094 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-17 | 2023-03-15 | PFE | DAMICO JENNIFER B. | SVP, Ctrl | S - Sale | $40.02 | -9,912 | 9,003 | -52% | -$396.7K |
| D | 2023-03-17 | 2023-02-24 | PFE | DAMICO JENNIFER B. | SVP, Ctrl | F - Tax | $41.75 | -360 | 16.4K | -2% | -$15.0K |
| D | 2023-03-17 | 2023-03-15 | PFE | DAMICO JENNIFER B. | SVP, Ctrl | A - Grant | $40.28 | +451 | 21.2K | +2% | +$18.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-15 | S | D | 9,912 | $40.02 | 9,003 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-24 | F | D | 360 | $41.75 | 16,383 | D | — | — | (F1) The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). |
| 3 | Derivative | Phantom Stock Units SSP | 2023-03-15 | A | A | 451 | $40.28 | 21,176 | D | — · — to — | 451 Common Stock | (F2) Each unit represents one phantom share of common stock. (F3) These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |